نتائج البحث

Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype.

• Authors : Kovach AE; Hematopathology, Division of Laboratory Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Subjects: Histone-Lysine N-Methyltransferase*/Histone-Lysine N-Methyltransferase*/Histone-Lysine N-Methyltransferase*/genetics ; Myeloid-Lymphoid Leukemia Protein*/Myeloid-Lymphoid Leukemia Protein*/Myeloid-Lymphoid Leukemia Protein*/genetics ; Gene Rearrangement*

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (12), pp. 1840-1852. Date of Electronic Publication: 2024 Aug 08.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

• Authors : Peroni E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, 35128 Padova, Italy.; Gottardi M

Subjects: Down Syndrome*/Down Syndrome*/Down Syndrome*/complications ; Down Syndrome*/Down Syndrome*/Down Syndrome*/genetics ; Down Syndrome*/Down Syndrome*/Down Syndrome*/pathology

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment.

• Authors : Jahromi FNA; Department of Hematology, School of Paramedical, Shiraz University of Medical Sciences, Shiraz, Iran.; Dowran R

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Exosomes*/Exosomes*/Exosomes*/metabolism

• Source: Cell communication and signaling : CCS [Cell Commun Signal] 2023 May 01; Vol. 21 (1), pp. 88. Date of Electronic Publication: 2023 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms.

• Authors : Jae Eun Jang¹; Jeong Moon Ryu¹; Min Hee Heo¹

• Source: Journal of Hospice & Palliative Care. Jun2023, Vol. 26 Issue 2, p69-79. 11p.

تفاصيل العنوان

EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms

• Authors : Li Li; Daiquan Zhang; Xinmei Cao

Subjects: EBF1; PAX5; MYC

• Source: Frontiers in Immunology, Vol 15 (2024)

تفاصيل العنوان

Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.

• Authors : Mohseni A; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Salehi F

Subjects: Exosomes*/Exosomes*/Exosomes*/metabolism ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/diagnosis

• Source: Stem cell research & therapy [Stem Cell Res Ther] 2025 Jan 07; Vol. 16 (1), pp. 6. Date of Electronic Publication: 2025 Jan 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512

تفاصيل العنوان

CAR-T Therapy Beyond B-Cell Hematological Malignancies.

• Authors : Canichella M; Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, Italy.; de Fabritiis P

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods

• Source: Cells [Cells] 2025 Jan 03; Vol. 14 (1). Date of Electronic Publication: 2025 Jan 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

Outcomes of non-COVID-19 critically ill patients with hematologic malignancies a 10-year single-center retrospective analysis.

• Authors : Galante O; Medical Intensive Care Unit, Soroka University Medical Center, Beer Sheva, Israel.; Faculty of Health Science, Ben Gurion University of the Negev, Beer Sheva, Israel.

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/mortality ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 115-122. Date of Electronic Publication: 2024 Sep 12.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis.

• Authors : Themlaoui A; Laboratory of Microbiology and Biochemistry (LR16SP01), Aziza Othmana Hospital, University Tunis El Manar, Tunis 1068, Tunisia.; Ancora M

Subjects: COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/mortality ; Virus Shedding*

• Source: Viruses [Viruses] 2024 Dec 31; Vol. 17 (1). Date of Electronic Publication: 2024 Dec 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

Resuscitation, yes or no ? the criteria for transferring patients with hematological malignancies to intensive care. A qualitative study.

• Authors : Bordier V; Palliative Care Unit, South Lyon Hospital Center, Civil Hospices of Lyon, Lyon, France.; Filbet M

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/psychology ; Qualitative Research*

• Source: BMC palliative care [BMC Palliat Care] 2024 Dec 19; Vol. 23 (1), pp. 285. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101088685 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-684X

تفاصيل العنوان